Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
KenChowder's Profile
Displaying 101-150 of 1190 result(s).
CYDY CytoDyn Inc
05/05/2025 5:04:23 PM
Here's what I find important about (23)
CYDY CytoDyn Inc
05/05/2025 11:20:52 AM
If I'm correct, dfwl, and my unders (4)
CYDY CytoDyn Inc
05/05/2025 10:21:53 AM
dfwl28 wrote: "Is an increased CCR5 (8)
CYDY CytoDyn Inc
05/04/2025 12:57:25 PM
Perplexity says this about Lumakras (8)
CYDY CytoDyn Inc
05/04/2025 8:04:56 AM
My69 wrote: "ESMO, the European Soc (18)
CYDY CytoDyn Inc
05/04/2025 2:58:01 AM
Nice post. I hadn't realized the FD (6)
CYDY CytoDyn Inc
05/03/2025 4:26:30 PM
On July 19, 2021, CYDY released a P (12)
CYDY CytoDyn Inc
05/01/2025 5:07:59 PM
In the space of 3 minutes, from 9:5 (5)
CYDY CytoDyn Inc
04/26/2025 9:16:54 AM
The animal testing in this trial s (13)
CYDY CytoDyn Inc
04/22/2025 4:41:23 AM
Celebrating Respert24 on his actual (11)
CYDY CytoDyn Inc
04/21/2025 3:53:54 AM
Key Board Member Identity Revealed. (6)
CYDY CytoDyn Inc
04/04/2025 10:02:03 AM
Funny you should say that, because (6)
CYDY CytoDyn Inc
04/01/2025 5:31:46 PM
Our bete noire Jeffrey Murray reti (6)
CYDY CytoDyn Inc
04/01/2025 3:56:26 AM
That would be NP's mother in law. I (2)
CYDY CytoDyn Inc
03/27/2025 6:14:27 PM
Not sure this is news -- seems more (4)
CYDY CytoDyn Inc
03/26/2025 11:32:55 AM
RECOVER not a part of that office, (4)
CYDY CytoDyn Inc
03/26/2025 9:51:04 AM
Office of Long Covid Research and P (1)
CYDY CytoDyn Inc
03/24/2025 6:34:42 PM
Great stuff, Jake. So it seems that (8)
CYDY CytoDyn Inc
03/24/2025 8:10:22 AM
Ramjet and House O'C believe BO off (14)
CYDY CytoDyn Inc
03/19/2025 4:34:05 AM
if we can identify why the women wh (6)
CYDY CytoDyn Inc
03/17/2025 10:38:51 AM
Sorry to mention this again, but it (3)
CYDY CytoDyn Inc
03/15/2025 7:17:41 AM
Unless I am reading this incorrectl (12)
CYDY CytoDyn Inc
03/08/2025 9:42:07 AM
I don't think these are ongoing tr (1)
CYDY CytoDyn Inc
03/05/2025 12:33:01 PM
Dave. My mind is going. I can feel (1)
CYDY CytoDyn Inc
03/05/2025 12:20:13 PM
I've still got the greatest confide (2)
CYDY CytoDyn Inc
03/05/2025 12:08:32 PM
I fully agree with you ER. We don†(6)
CYDY CytoDyn Inc
03/05/2025 9:36:55 AM
This was a buyout not a partnershi
CYDY CytoDyn Inc
03/05/2025 8:58:11 AM
What an indication might be worth - (29)
CYDY CytoDyn Inc
03/04/2025 11:20:13 AM
Okay, I'll stop talking about this (3)
CYDY CytoDyn Inc
03/04/2025 9:57:32 AM
Question about the trading -- anyon (3)
CYDY CytoDyn Inc
03/04/2025 3:12:04 AM
As you surely know, Seemingly, NP d (8)
CYDY CytoDyn Inc
03/03/2025 8:51:09 AM
Actually, now that I think about it (6)
CYDY CytoDyn Inc
03/03/2025 8:43:47 AM
Yes, that could well be true. All I (19)
CYDY CytoDyn Inc
03/03/2025 3:29:25 AM
Thanks, MGK. Ohm can respond bette (6)
CYDY CytoDyn Inc
02/27/2025 11:07:29 AM
Thanks, but I can't see anything..
CYDY CytoDyn Inc
02/26/2025 12:54:41 PM
Speaking of sucking -- all those pe (11)
CYDY CytoDyn Inc
02/26/2025 10:29:54 AM
In his last post, MY posited the th (6)
CYDY CytoDyn Inc
02/26/2025 7:24:57 AM
Question: What if Three White Soldi (1)
CYDY CytoDyn Inc
02/26/2025 6:29:00 AM
What if the cup has a saucer? What (6)
CYDY CytoDyn Inc
02/24/2025 12:39:43 PM
If I were the Gates Foundation, I (9)
CYDY CytoDyn Inc
02/24/2025 9:26:22 AM
Great news. I wonder if Nader's mo (4)
CYDY CytoDyn Inc
02/21/2025 3:24:17 AM
In case you didn't see what My was (15)
CYDY CytoDyn Inc
02/20/2025 4:48:59 PM
One factor is that you have to con (21)
CYDY CytoDyn Inc
02/20/2025 11:22:06 AM
Salvage therapy or rescue therapy i (17)
CYDY CytoDyn Inc
02/18/2025 5:41:49 PM
Are you really referring criticall (8)
CYDY CytoDyn Inc
02/18/2025 4:54:16 PM
Citadel is shocked, shocked to hea (15)
CYDY CytoDyn Inc
02/18/2025 8:18:59 AM
Dr. Lataillade did mention HIV, Sun (4)
CYDY CytoDyn Inc
02/16/2025 2:37:14 AM
Nice catch. Incidentally, GSK is pa (9)
CYDY CytoDyn Inc
02/15/2025 4:58:21 PM
GSK recently announced a 400% incr (11)
CYDY CytoDyn Inc
02/15/2025 3:34:51 PM
I know that in the fall GSK settled (2)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Impinj Experiences a 22% Surge Following Impressive Q2 Results
  • Federal Reserve Decision Sparks Diverse Market Reactions
  • SPIE Reports Strong 2025 Half-Year Results with Growth and M&A
  • JCDecaux Reports Strong Half-Year 2025 Results with Digital Growth
  • EfTEN Real Estate Fund Delivers Strong Q2 Results in 2025
  • ING Reports Impressive 2Q2025 Financial Performance Growth
  • AS Ekspress Grupp Reports Growth Amid Economic Challenges
  • CrĂ©dit Agricole S.A.'s Strong Growth and Future Plans Unveiled
  • Ipsen's Strong Half-Year Performance Leads to Positive Guidance
  • Syensqo Announces Launch of New Share Buyback Tranche
  • Corbion's Impressive H1 2025 Results Showcase Growth
  • Bekaert's Upcoming Share Buyback Program and Insights
  • Pharming Group's Financial Upsurge: Q2 Highlights and Future Outlook
  • Clariant Q2 2025: Profit Margins Rise Amid Market Challenges
  • Ontex Delivers Mixed Results Amid Market Challenges and Changes
  • Arcadis Reports Strong Q2 and Half Year 2025 Performance
  • dsm-firmenich Showcases Robust H1 2025 Performance and Vision
  • AS Ekspress Grupp Reports Positive Growth Amid Economic Pressures
  • SCOR Reports Strong Q2 2025 Financial Performance with EUR 226M Gain
  • Empowering Youth Against Corruption: ICAC's Landmark Program
  • Cyberattacks Continue to Surge: Insights from Semperis Study
  • Renault SA Announces 2025 H1 Financial Report Availability
  • SCOR Reports Impressive Second Quarter Results with EUR 226M Income
  • Ipsen's Robust Half-Year Performance and Optimistic Outlook
  • Ontex's Strategic Shift Amidst H1 Revenue Challenges
  • Syensqo Reports Strong Q2 Performance Amid Challenges
  • argenx Achieves Milestones in 2025: Q2 Financial Highlights
  • dsm-firmenich Achieves Strong Growth in H1 2025 Results
  • Arcadis Reports Strong Q2 and Half-Year Results for 2025
  • Clariant's Q2 2025: Resilient Profitability Amidst Challenges
  • Pharming Group Achieves Impressive Revenue Growth in 2025
  • Fagron Reports Impressive H1 Growth, Expands Market Presence
  • Corbion's 2025 Half-Year Results Exceed Expectations
  • Renault Group’s Strong Fundamentals Fuel Growth in Second Half
  • CrĂ©dit Agricole's Robust Performance in 2025 Revealed
  • SPIE Achieves Record-High H1 Earnings and Robust Growth Prospects
  • JCDecaux Reports Strong Half-Year 2025 Financial Performance
  • ING's 2Q2025 Results Show Strong Growth Amid Challenges
  • Societe Generale Reports Exceptional Q2 and H1 2025 Financial Results
  • Societe Generale's Impressive H1 2025 Financial Results
  • Amcor's Upcoming Fiscal Quarter Results Announcement Details
  • Meta Platforms Pursues External Funding to Boost AI Initiatives
  • Metalpha Achieves Record Growth and Profits in 2025 Fiscal Year
  • Metalpha Achieves Remarkable Growth and Profit Amid Digital Trends
  • Trump's New Trade Strategy: Fostering Ties with Pakistan
  • Kelso Technologies Inc. Announces Positive Financial Trends
  • Caliber Announces Earnings Call and Financial Update Plans
  • Kelso Technologies Inc. Reports Positive Q2 Financials and Future Outlook
  • BioArctic's Lecanemab Shows Long-Term Efficacy and Safety
  • BioArctic's Lecanemab: Demonstrating Sustained Efficacy
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site